139 related articles for article (PubMed ID: 19423006)
1. Application of highly sensitive UPLC-MS to determine biodistribution at tracer doses: validation with the 5-HT1A ligand [(18)F]FPWAY.
Ma Y; Lang L; Reyes L; Tokugawa J; Jagoda EM; Kiesewetter DO
Nucl Med Biol; 2009 May; 36(4):389-93. PubMed ID: 19423006
[TBL] [Abstract][Full Text] [Related]
2. Mapping the target localization and biodistribution of non-radiolabeled VMAT2 ligands in rat brain.
Deng A; Wu X; Zhou X; Zhang Y; Yin W; Qiao J; Zhu L
AAPS J; 2014 May; 16(3):592-9. PubMed ID: 24706374
[TBL] [Abstract][Full Text] [Related]
3. Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT.
Jagoda EM; Lang L; Tokugawa J; Simmons A; Ma Y; Contoreggi C; Kiesewetter D; Eckelman WC
Synapse; 2006 May; 59(6):330-41. PubMed ID: 16440292
[TBL] [Abstract][Full Text] [Related]
4. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
Defraiteur C; Lemaire C; Luxen A; Plenevaux A
Nucl Med Biol; 2006 Jul; 33(5):667-75. PubMed ID: 16843842
[TBL] [Abstract][Full Text] [Related]
5. Distribution of the 5-HT(1A) receptor antagonist [ (18)F]FPWAY in blood and brain of the rat with and without isoflurane anesthesia.
Tokugawa J; Ravasi L; Nakayama T; Lang L; Schmidt KC; Seidel J; Green MV; Sokoloff L; Eckelman WC
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):259-66. PubMed ID: 17021813
[TBL] [Abstract][Full Text] [Related]
6. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.
Tipre DN; Zoghbi SS; Liow JS; Green MV; Seidel J; Ichise M; Innis RB; Pike VW
J Nucl Med; 2006 Feb; 47(2):345-53. PubMed ID: 16455642
[TBL] [Abstract][Full Text] [Related]
9. N-(4-[(18)F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT(1A) receptors.
García G; Abet V; Alajarín R; Álvarez-Builla J; Delgado M; García-García L; Bascuñana-Almarcha P; Peña-Salcedo C; Kelly J; Pozo MA
Eur J Med Chem; 2014 Oct; 85():795-806. PubMed ID: 25171752
[TBL] [Abstract][Full Text] [Related]
10. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
Laćan G; Plenevaux A; Rubins DJ; Way BM; Defraiteur C; Lemaire C; Aerts J; Luxen A; Cherry SR; Melega WP
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2256-66. PubMed ID: 18604533
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.
Peyronneau MA; Saba W; Goutal S; Damont A; Dollé F; Kassiou M; Bottlaender M; Valette H
Drug Metab Dispos; 2013 Jan; 41(1):122-31. PubMed ID: 23065531
[TBL] [Abstract][Full Text] [Related]
13. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.
Saigal N; Bajwa AK; Faheem SS; Coleman RA; Pandey SK; Constantinescu CC; Fong V; Mukherjee J
Synapse; 2013 Sep; 67(9):596-608. PubMed ID: 23504990
[TBL] [Abstract][Full Text] [Related]
15. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.
Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT
J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous in-vivo receptor occupancy assays for serotonin 1A, 2A, and dopamine 2 receptors with the use of non-radiolabelled tracers: Proposed method in screening antipsychotics.
Thentu JB; Nirogi R; Bhyrapuneni G; Ajjala DR; Aleti RR; Palacharla RC
J Pharmacol Toxicol Methods; 2017; 85():22-28. PubMed ID: 28063918
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans.
Mukherjee J; Bajwa AK; Wooten DW; Hillmer AT; Pan ML; Pandey SK; Saigal N; Christian BT
J Comp Neurol; 2016 May; 524(7):1457-71. PubMed ID: 26509362
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635.
Lang L; Jagoda E; Ma Y; Sassaman MB; Eckelman WC
Bioorg Med Chem; 2006 Jun; 14(11):3737-48. PubMed ID: 16488611
[TBL] [Abstract][Full Text] [Related]
19. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.
Plenevaux A; Weissmann D; Aerts J; Lemaire C; Brihaye C; Degueldre C; Le Bars D; Comar D; Pujol J; Luxen A
J Neurochem; 2000 Aug; 75(2):803-11. PubMed ID: 10899958
[TBL] [Abstract][Full Text] [Related]
20. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
